In Stock
5-Amino-1MQ
50 mg
Orders placed before 2 p.m. ET ship the same business day. Free shipping on orders $250+.
BPC-157 + TB-500 is a 10mg research blend containing 5mg of BPC-157 and 5mg of TB-500 (thymosin beta-4) in one lyophilized vial. Both peptides are studied in experimental models of tissue repair, cell migration and angiogenesis.
This blend combines two of the most widely studied peptides in tissue-repair research. BPC-157 (body protection compound 157) is a synthetic 15-amino-acid peptide derived from a protein found in human gastric juice. TB-500 is the research name for synthetic thymosin beta-4 (Tβ4), a 43-amino-acid peptide that occurs naturally in most human cells.
Each vial contains 5mg of each peptide, for 10mg in total. Combining them lets researchers study two distinct repair-related pathways in the same experimental model.
BPC-157 has been studied mainly in animal models of gastrointestinal, tendon, ligament and muscle injury. Proposed mechanisms include effects on angiogenesis, nitric oxide signalling and growth-factor pathways that support fibroblast activity. It is notably stable in gastric juice, which is unusual for a peptide.
Thymosin beta-4 is the main actin-sequestering protein in many cell types. By binding monomeric G-actin, it regulates actin polymerisation and the cytoskeletal remodelling that cells need in order to migrate. Research links this activity to cell migration, angiogenesis and cell survival after injury.
In a rat Achilles tendon model, BPC-157 was reported to improve functional, biomechanical and histological measures of healing (Staresinic et al., Journal of Orthopaedic Research, 2003). Its gastrointestinal research and stability in gastric juice are reviewed in Sikiric et al., Current Pharmaceutical Design, 2011.
For thymosin beta-4, a widely cited study reported that it activated integrin-linked kinase and promoted cardiac cell migration, survival and repair in a mouse model of cardiac injury (Bock-Marquette et al., Nature, 2004). These are preclinical findings, cited for scientific context only; BPC-157 is not approved by any drug regulator for human use.
Each 10mg vial contains 5mg of BPC-157 and 5mg of TB-500, a 1:1 ratio.
TB-500 is the name commonly used in the research market for synthetic thymosin beta-4 (Tβ4). The term is also sometimes used for a shorter active fragment of Tβ4, so it is worth checking the test report for what a given product contains.
Store unopened vials in a cool, dry place away from direct light, with refrigeration recommended for long-term storage. After reconstitution, keep the vial refrigerated at 2–8°C.
Published literature is summarised for scientific context only. It is not a claim about this product, and this product is not for human or veterinary use.
Store unopened vials in a cool, dry environment away from direct light. For long-term storage, refrigeration is recommended. After reconstitution, keep refrigerated at 2–8°C and protect from direct light.
Not for human consumption. This product is sold exclusively as a research compound for in vitro and laboratory use by qualified researchers. It is not a drug, supplement, or cosmetic, is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease. No dosing, administration, or therapeutic claims are made or implied.
Published literature referenced on this page is provided for scientific context only and does not constitute a claim about this product or evidence of safety or efficacy in any organism.
By purchasing this product, you confirm that it will be used for legitimate research purposes in accordance with applicable laws and regulations.
